(KATU) — Oregon Attorney General Dan Rayfield announced a $9.25 million settlement with pharmaceutical companies AbbVie and Besins over their alleged monopoly on testosterone replacement gels.

Some of the settlement will go to Oregon Medicaid, which paid the inflated prices for the testosterone gel, and part of it will go to the protection and education fund for the Oregon Department of ...

Wash hands after application. Allow gel to dry before it touches clothing. Not for use in women. Not interchangeable with other topical testosterone products. Other persons (esp. children ...

As Healio previously reported, findings from the TRAVERSE trial revealed the percentage of men with hypogonadism who received transdermal 1.62% testosterone gel (AbbVie) had a similar risk for a ...

Current FDA-approved testosterone formulations include oral, topical gel, transdermal patch and injection. Testosterone is approved only for use in men who lack or have low levels of the hormone ...